Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
0.9422
-0.0678 (-6.71%)
Nov 20, 2026, 4:00 PM EST - Market closed
Stereotaxis Revenue
Stereotaxis had revenue of $8.93M in the quarter ending September 30, 2026, with 19.57% growth. This brings the company's total for the last twelve months to $31.53M, up 4.83% year-over-year. In the year 2025, Stereotaxis had annual revenue of $32.38M with 20.28% growth. That makes Stereotaxis the 31,097th largest company in the world by revenue and 4,090th in the United States.
Revenue (ttm)
$31.53M
Revenue Growth
+4.83%
P/S Ratio
3.01
Revenue / Employee
$240,672
Employees
131
Market Cap
95.03M
Revenue by Geography
- International 19.51M 60.3%
- United States 12.87M 39.7%
Fiscal year ended Dec 31, 2025 See the full Stereotaxis breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.38M | 5.46M | 20.28% |
| Dec 31, 2024 | 26.92M | 147.00K | 0.55% |
| Dec 31, 2023 | 26.77M | -1.38M | -4.89% |
| Dec 31, 2022 | 28.15M | -6.87M | -19.63% |
| Dec 31, 2021 | 35.02M | 8.39M | 31.51% |
| Dec 31, 2020 | 26.63M | -2.27M | -7.86% |
| Dec 31, 2019 | 28.90M | -444.07K | -1.51% |
| Dec 31, 2018 | 29.35M | -1.80M | -5.77% |
| Dec 31, 2017 | 31.14M | -1.02M | -3.17% |
| Dec 31, 2016 | 32.16M | -5.51M | -14.63% |
| Dec 31, 2015 | 37.67M | 2.66M | 7.61% |
| Dec 31, 2014 | 35.01M | -3.02M | -7.94% |
| Dec 31, 2013 | 38.03M | -8.53M | -18.32% |
| Dec 31, 2012 | 46.56M | 4.58M | 10.90% |
| Dec 31, 2011 | 41.99M | -12.06M | -22.32% |
| Dec 31, 2010 | 54.05M | 2.90M | 5.67% |
| Dec 31, 2009 | 51.15M | 10.78M | 26.72% |
| Dec 31, 2008 | 40.37M | 1.07M | 2.71% |
| Dec 31, 2007 | 39.30M | 12.11M | 44.52% |
| Dec 31, 2006 | 27.19M | 12.17M | 80.96% |
| Dec 31, 2005 | 15.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| OraSure Technologies | 116.23M |
| Sanara MedTech | 111.91M |
| Harvard Bioscience | 89.41M |
| Pro-Dex | 79.58M |
| KORU Medical Systems | 46.27M |
| Utah Medical Products | 34.92M |
| Precision Optics Corporation | 33.00M |
| Nephros | 21.58M |
STXS News
- 11 days ago - Stereotaxis price target lowered to $2 from $3 at TD Cowen - TheFly
- 11 days ago - Stereotaxis Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - Stereotaxis Earnings release: Q3 2026 - Filings
- 11 days ago - Stereotaxis Quarterly report: Q3 2026 - Filings
- 11 days ago - Stereotaxis reports Q3 EPS (7c), consensus (5c) - TheFly
- 11 days ago - Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates - GlobeNewsWire
- 11 days ago - Stereotaxis Announces Convertible Note Financing of Up To $24 Million - GlobeNewsWire
- 20 days ago - First-in-Human Coronary Intervention Study Results of Robocath's Next-Generation Robotic System Highlighted at TCT - GlobeNewsWire